Johnson & Johnson (JNJ) income statement
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 27, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3083% above fair value
$267.14−5.56 (-2.04%)
Close on Nov 19, 2026Market cap $643.09BP/E 40.5Yield 1.92%
Johnson & Johnson income statement
Ratios
Latest available, balances at Sep 27, 2026
Profitability, TTM
- Gross margin
- 67.6%
- Operating margin
- –
- Net margin
- 16.2%
- Return on equity, FY2025
- 35.0%
Financial strength
- Current ratio
- 1.02
- Debt to equity
- 0.55
- Debt to assets
- 22.6%
- Cash to current liabilities
- 30.5%
Valuation
- P/E ratio
- 40.5
- Price to sales
- 6.47
- Price to book
- 7.89
- Dividend yield
- 1.92%
See a number that looks wrong?